Management of multivessel coronary disease in STEMI patients: A systematic review and meta-analysis

被引:36
|
作者
Moretti, Claudio [1 ]
D'Ascenzo, Fabrizio [1 ]
Quadri, Giorgio [1 ]
Omede, Pierluigi [1 ]
Montefusco, Antonio [1 ]
Taha, Salma [1 ]
Cerrato, Enrico [1 ]
Colaci, Chiara [1 ]
Chen, Shao-Liang [2 ]
Biondi-Zoccai, Giuseppe [3 ]
Gaita, Fiorenzo [1 ]
机构
[1] Univ Turin, Citta Salute & Sci, Dept Internal Med, Div Cardiol, I-10124 Turin, Italy
[2] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China
[3] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, I-00185 Rome, Italy
关键词
STEMI; Multivessel disease; Complete revascularization; ELEVATION MYOCARDIAL-INFARCTION; FRACTIONAL FLOW RESERVE; ARTERY-DISEASE; MEDICAL THERAPY; COMPLETE REVASCULARIZATION; VESSEL REVASCULARIZATION; RANDOMIZED-TRIAL; UNSTABLE ANGINA; CULPRIT VESSEL; PLAQUE RUPTURE;
D O I
10.1016/j.ijcard.2014.10.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Appropriate management for patients with multivessel coronary disease presenting with ST segment Elevation Myocardial Infarction (STEMI) remains to be defined. Methods and results: Medline and Cochrane Library were searched for randomized controlled trials (RCTs) or observational studies adjusted with multivariate analysis, reporting about STEMI patients with multivessel coronary disease treated with either a culprit only or complete revascularization strategy, excluding patients in cardiogenic shock. Prespecified analysis was performed according to the strategy of complete revascularization, either during the same procedure of primary percutaneous coronary intervention (PCI) or during the index hospitalization. MACE (a composite and mutually exclusive end point of death or myocardial infarction or revascularization) at follow-up of at least one year was the primary end point. 9 studies with 4686 patients compared culprit only versus complete PCI performed during the primary PCI. Rates of MACE did not differ at 90 days (OR 0.70 [0.38, 1.27], I-2 = 0%) or at 1 year (1-2.5) (OR 0.70 [0.47, 1.03], I-2 = 0%). No significant difference was found for the components of the primary outcome, apart from a reduction in repeated revascularization for patients undergoing complete PCI during the STEMI procedure (OR 0.62 [0.39, 0.98], I-2 = 0%). 6 studies (1 RCT) with 5855 patients compared culprit only lesions versus complete PCI performed during index hospitalization. 90 day risk of MACE did not differ nor 1 year (1-2.5) MACE (OR 0.86 [0.62, 1.08], I-2 = 0%), with a similar reduction in repeated revascularization (0.60 [0.40, 0.90], I-2 = 0%). Conclusions: Complete revascularization performed during primary PCI or index hospitalizations for patients presenting with STEMI appears safe at short term follow-up and offers a reduction in repeated revascularization at one year. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:552 / 557
页数:6
相关论文
共 50 条
  • [41] Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials
    Kofler, Thomas
    Kurmann, Reto
    Lehnick, Dirk
    Cioffi, Giacomo Maria
    Chandran, Sujay
    Attinger-Toller, Adrian
    Toggweiler, Stefan
    Kobza, Richard
    Moccetti, Federico
    Cuculi, Florim
    Jolly, Sanjit S.
    Bossard, Matthias
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (16):
  • [42] Risk of Coronary Artery Disease in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
    Ungprasert, Patompong
    Koster, Matthew J.
    Warrington, Kenneth J.
    Matteson, Eric L.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Prognostic impact of malnutrition in patients with coronary artery disease: a systematic review and meta-analysis
    He, Fengling
    Huang, Haoxiang
    Xu, Wenlong
    Cui, Kai
    Ruan, Yifei
    Guo, Yuetong
    Wang, Junfen
    Bin, Jianping
    Wang, Yuegang
    Chen, Yanmei
    NUTRITION REVIEWS, 2023, 82 (08) : 1013 - 1027
  • [44] Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis
    Ungprasert, Patompong
    Srivali, Narat
    Kittanamongkolchai, Wonngarm
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (04)
  • [45] Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis
    Gu, Chunru
    Dong, Liyan
    Chai, Lu
    Tong, Zhenhua
    Gao, Fangbo
    Ageno, Walter
    Romeiro, Fernando Gomes
    Qi, Xingshun
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2025, 13 (02) : 93 - 104
  • [46] CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
    Jain, Vardhmaan
    Gupta, Kartik
    Nanda, Navin
    Bajaj, Navkaranbir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1355 - 1355
  • [47] Safety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
    Ullah, Waqas
    Gowda, Smitha Narayana
    Fischman, David
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 23 : 1 - 6
  • [48] Psychosocial interventions for patients with coronary heart disease and depression: A systematic review and meta-analysis
    Ski, Chantal F.
    Jelinek, Michael
    Jackson, Alun C.
    Murphy, Barbara M.
    Thompson, David R.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2016, 15 (05) : 305 - 316
  • [49] The Risk of Coronary Heart Disease in Patients with Kidney Stones: A Systematic Review and Meta-analysis
    Cheungpasitporn, Wisit
    Thongprayoon, Charat
    Mao, Michael A.
    O'Corragain, Oisin A.
    Edmonds, Peter J.
    Erickson, Stephen B.
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (11) : 580 - 585
  • [50] A systematic review and meta-analysis of coronary artery disease and revascularization in lung transplant patients
    Fialka, Nicholas M.
    Bozso, Sabin J.
    El-Andari, Ryaan
    Kang, Jimmy J. H.
    Laing, Bryce
    Meyer, Steven R.
    Nagendran, Jayan
    Nagendran, Jeevan
    CORONARY ARTERY DISEASE, 2022, 33 (08) : 661 - 669